- Home
- SQNS vs CRVO Comparison
SQNS vs CRVO Comparison
Compare SQNS & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SQNS
- CRVO
- Stock Information
- Founded
- SQNS 2003
- CRVO 2001
- Country
- SQNS France
- CRVO United States
- Employees
- SQNS N/A
- CRVO N/A
- Industry
- SQNS Semiconductors
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- SQNS Technology
- CRVO Health Care
- Exchange
- SQNS Nasdaq
- CRVO Nasdaq
- Market Cap
- SQNS 85.7M
- CRVO 95.4M
- IPO Year
- SQNS 2011
- CRVO N/A
- Fundamental
- Price
- SQNS $1.92
- CRVO $10.85
- Analyst Decision
- SQNS Strong Buy
- CRVO Strong Buy
- Analyst Count
- SQNS 1
- CRVO 8
- Target Price
- SQNS $7.50
- CRVO $25.43
- AVG Volume (30 Days)
- SQNS 62.7K
- CRVO 13.9M
- Earning Date
- SQNS 02-11-2025
- CRVO 05-13-2025
- Dividend Yield
- SQNS N/A
- CRVO N/A
- EPS Growth
- SQNS N/A
- CRVO N/A
- EPS
- SQNS 2.00
- CRVO N/A
- Revenue
- SQNS $36,762,000.00
- CRVO $9,737,974.00
- Revenue This Year
- SQNS N/A
- CRVO N/A
- Revenue Next Year
- SQNS $95.51
- CRVO N/A
- P/E Ratio
- SQNS $1.06
- CRVO N/A
- Revenue Growth
- SQNS 9.36
- CRVO 36.29
- 52 Week Low
- SQNS $0.95
- CRVO $1.80
- 52 Week High
- SQNS $4.28
- CRVO $25.92
- Technical
- Relative Strength Index (RSI)
- SQNS 32.67
- CRVO 64.66
- Support Level
- SQNS $2.10
- CRVO $8.64
- Resistance Level
- SQNS $2.18
- CRVO $14.00
- Average True Range (ATR)
- SQNS 0.14
- CRVO 2.54
- MACD
- SQNS -0.00
- CRVO 0.18
- Stochastic Oscillator
- SQNS 8.33
- CRVO 58.62
About SQNS Sequans Communications S.A.
Sequans Communications SA is a designer, developer, and supplier of cellular semiconductor solutions for broadband Internet of Things (IoT) markets. Its solutions incorporate baseband processor and radio frequency, transceiver integrated circuits, along with its proprietary signal processing techniques, algorithms, and software stacks. The company's solutions serve as the core wireless broadband communications platform in devices, including smartphones, USB dongles, portable routers, laptops, netbooks, tablets, and other consumer multimedia and industrial devices. Its geographical segments are Taiwan, Korea, China (including Hong Kong), the Rest of Asia, the United States and the Rest of the world.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.